BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12494710)

  • 1. [Acute myeloid leukemia].
    Bol P
    Ned Tijdschr Tandheelkd; 2002 Nov; 109(11):463-4. PubMed ID: 12494710
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
    Baker KS; Loberiza FR; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ
    J Clin Oncol; 2005 Oct; 23(28):7032-42. PubMed ID: 16145067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies.
    Lassaletta A; Ramírez M; Montero JM; González-Vicent M; Balas A; Madero L; Díaz MA
    Leukemia; 2005 Apr; 19(4):504-6. PubMed ID: 15729381
    [No Abstract]   [Full Text] [Related]  

  • 4. Availability and appropriateness of allo-BMT for CML: the Italian experience.
    Marmont A; Gualandi F
    Bone Marrow Transplant; 1995 Aug; 16(2):325-6. PubMed ID: 7581161
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone marrow transplantation in chronic myeloid leukemia. Results in 27 patients].
    Fernández-Rañada JM; Vázquez L; Figuera A; Lozano M; Fernández-Garese D; Gómez Reino F; Fernández-Villalta MJ; Steegmann JL; Arranz R; Gómez N
    Rev Clin Esp; 1988 Dec; 183(9):463-7. PubMed ID: 3070658
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment in haematopoietic stem cell transplantation.
    Gratwohl A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):119-24. PubMed ID: 17448952
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
    Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
    Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
    Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome?
    Melillo L; Specchia G; Ferrara F; Minervini MM; Pastore D; Carella AM
    Haematologica; 2003 Jun; 88(6):715-8. PubMed ID: 12801851
    [No Abstract]   [Full Text] [Related]  

  • 10. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
    Bacher U; Klyuchnikov E; Zabelina T; Ottinger H; Beelen DW; Schrezenmeier H; Ehninger G; Müller C; Berger J; Suttorp M; Kolb HJ; Kröger N; Zander AR
    Ann Hematol; 2009 Dec; 88(12):1237-47. PubMed ID: 19319532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].
    Meng FY; Sun J; Liu QF; Xu D; Yang LJ; Song LL; Liu XL; Xu B; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1301-2, 1306. PubMed ID: 14678896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic peripheral blood and bone marrow stem cell transplantation for chronic myelogenous leukemia: single center study from Iran.
    Ghavamzadeh A; Iravani M; Jabehdar-Maralani P; Hajrasouliha A; Tavakoli S
    Haematologica; 2003 Apr; 88(4):ELT13. PubMed ID: 12681990
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
    Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic blood stem cell transplantation in advanced chronic myeloid leukemia--high response rate associated with increased chronic graft-versus-host disease.
    Sayer HG; Kasper C; Mügge LO; Schilling K; Scholl S; Höffken K
    Haematologica; 2003 Jul; 88(7):831-3. PubMed ID: 12857566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of estrogen-progestin replacement therapy after bone marrow transplantation].
    Bellati U; Iammarrone E; Bavaro P; Mattaeis RD; Bizzarri M; Carabella G; Torlontano G
    Minerva Ginecol; 1996 Sep; 48(9):351-4. PubMed ID: 8999381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
    Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.